2023
article
OpenAlex
Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag et autres
BACKGROUND: In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), finerenone, a nonsteroidal mineralocorticoid receptor antagonist, reduces cardiovascular and kidney failure outcomes. Finerenone also lowers the urine albumin-to-creatinine ratio (UACR). Whether finerenone-induced change in UACR mediates cardiovascular and kidney …
us, gb, de, es, dk, gr, pl
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Peter R Rossing, Stefan D. Anker, Gerasimos S Filippatos, Bertram Pitt et autres
OBJECTIVE: Finerenone reduced the risk of kidney and cardiovascular events in people with chronic kidney disease (CKD) and type 2 diabetes in the FIDELIO-DKD and FIGARO-DKD phase 3 studies. Effects of finerenone on outcomes in patients taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) …
dk, de, gr, us, es, gb
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
Yang Zhou, Xiangping Chai, Huaping He, Wen Peng et autres
Abstract Background: Delayed or misdiagnosed aortic dissection can lead to death and morbidity. Ischemia-modified albumin (IMA) measures the cobalt binding capability and has been associated with mortality in patients with acute aortic dissection (AAD). However, it is unknown whether IMA levels can …
cn
(code pays fourni par la source)
2018
article
OpenAlex
Yuanyuan Zhang, Zhaofen Wang, Bin Li, Wen Peng et autres
Objectives: To evaluate the diagnostic value of high-resolution melting curve (HRM) analysis to isoniazid-resistant Mycobacterium tuberculosis (MTB) derived from patients on the Qinghai-Tibet Plateau, compared with DNA sequencing. Methods: A total of 96 clinical isoniazid (INH) resistant isolates, determined by drugs susceptibility …
2015
article
OpenAlex
Yao-xue Guo, Xue Fei Xu, Qi Zhi Zhang, Li Chun et autres
Co-treatment of isoniazid (INH) and rifampicin (RFP) is well known for clinically apparent liver injury. However, the mechanism of INH/RFP-induced liver injury is controversial. Emerging evidence shows links between inhibition of bile acids transporters and drug-induced liver injury (DILI). The present study …
cn
(code pays fourni par la source)